Clinical Effectiveness Expected weight loss outcomes with Wegovy Alright, let's get down to the nitty-gritty
Frequently Asked Questions How does retatrutide work differently than semaglutide or tirzepatide
According to the FDA-approved prescribing information, injection site reactions occurred in 1.4% of Ozempic patients versus 0.6% in placebo groups
The lawsuit The lawsuit consolidates dozens of cases brought by patients who took one of these five drugs
Challenges Remain for Global Trans-fat Elimination Efforts in Preventing Coronary Heart Disease Aug 05, 2024 by Nathan Gray, CRTonline.org Since accelerated global efforts to eliminate the use of industrially produced trans-fat (iTFA) began, 43 countries have adopted best practice regulations, protecting an additional 3.2 billion people against coronary heart disease (CHD)
The seemingly paradoxical situation: in the approval trials, tirzepatide (5%) sits slightly above semaglutide/Wegovy (3%), while in the FAERS reporting system it is the other way round